×
Customize
?
Start
Cancer Types
Quick Links
Events
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Patients with high-risk stage 3 melanoma who experienced an immune-related side effect after treatment with adjuvant Keytruda had reduced risk for disease recurrence, compared with those on the placebo arm.
Kristie L. Kahl
The Food and Drug Administration granted a priority review to belantamab mafodotin for the treatment of patients with relapsed or refractory multiple myeloma.
Kristie L. Kahl
Oncoprex in combination with Tagrisso received fast track designation from the Food and Drug Administration to treat patients with non-small cell lung cancer.
More
Voices
Jeremy Pivor
With the start of a new decade, a brain cancer patient discovers what may be the most courageous way to move forward in his life.
Sherry B. Hanson
One cancer survivor details how her immunotherapy changed her cancer journey for the better, and how ongoing trials of immunotherapy are looking to change the cancer landscape for the better.
Steve Rubin
Having loved ones by your side is right up there in importance with any aspect of healing from cancer.
More
CURE Connections®
Dr. Ian Flinn provides a glimpse at an upcoming Cure Connections program, which will focus on chemotherapy-free treatment options in chronic lymphocytic leukemia.
Before Dr. Eskander turns to the future treatment of ovarian cancer, participants consider how the treatment journey can affect caregivers.
A breakdown of the support networks patients can build and rely on as they receive treatment for ovarian cancer.
More
Videos
Ann McMullin
Ann McMullin fought for her son to be properly diagnosed and is advocating for more education among medical professionals of rare diseases like her son’s essential thrombocythemia.
Dr. David C. Fajenbaum
As a guest speaker at the 2019 MPN Heroes ® Recognition Ceremony, Dr. David C. Fajenbaum had the chance to discuss how translational research is a vital part of getting the right treatment to patients with cancer.
Dr. Mario Sznol
Because they have been found to be effective in the treatment of many types of cancer, including melanoma, immunotherapy drugs like anti-PD-1 agents and anti-CTLA4 therapies should not be discounted because of their toxicities.
More
Podcasts
Kristie L. Kahl
In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with the associate director of the Information Resource Center at the Leukemia and Lymphoma Society on support groups and other recourses available for those affected by blood cancer.
Kristie L. Kahl and Katie Kosko
In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with breast cancer survivor Felicia Robinson, who recently wrote a book with her daughter on their personal experiences with the various aspects of a life-changing diagnosis.
Kristie L. Kahl
In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Cesar Rodriguez about precision medicine, and his recent trek to Patagonia with Moving Mountains for Multiple Myeloma.
More
Recipes
Rachel Wong, RD, CSO, LD
Dive into fall with a nutritious and versatile winter squash.
Jessica Skarzynski
We’re ending our #CURESummerSnacktime series with a raspberry mint smoothie recipe that’s sure to cool you down as we enter the last days of summer!
Jessica Skarzynski
This avocado and herb recipe is packed with flavor and health benefits.
More
